Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.

Findling, Robert L; Childress, Ann C; Cutler, Andrew J; Gasior, Maria; Hamdani, Mohamed; Ferreira-Cornwell, M Celeste; Squires, Liza

Findling, Robert L; Childress, Ann C; Cutler, Andrew J; Gasior, Maria; Hamdani, Mohamed; Ferreira-Cornwell, M Celeste; Squires, Liza.

Affiliation

Findling RL; University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA. Robert.Findling@UHhospitals.org

J Am Acad Child Adolesc Psychiatry ; 50(4): 395-405, 2011 Apr.

Article in En | MEDLINE | ID: mdl-21421179

Subject(s)

Attention Deficit Disorder with Hyperactivity/drug therapy; Central Nervous System Stimulants/adverse effects; Central Nervous System Stimulants/therapeutic use; Dextroamphetamine/adverse effects; Dextroamphetamine/therapeutic use; Adolescent; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Personality Assessment/statistics & numerical data; Psychometrics; Quality of Life/psychology; Treatment Outcome; United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Dextroamphetamine / Central Nervous System Stimulants Type of study: Clinical_trials Limits: Adolescent / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: J Am Acad Child Adolesc Psychiatry Journal subject: PEDIATRIA / PSIQUIATRIA Year: 2011 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google